Advanced Enzyme Technologies has informed that the Security Allotment Committee of the Board of Directors of the Company, at its meeting held today, has approved the allotment of 45,650 Equity Shares of face value of ? 2 per share pursuant to the Exercise of Options under Advanced Enzyme Technologies- Employees Stock Options Scheme (ESOS) 2022. These shares shall rank with the existing equity shares of the Company in all respects. Consequent to the said allotment, the paid-up share capital of the Company stands increased from ? 22,37,62,300 comprising of 11,18,81,150 Equity Shares of ? 2 each to ? 22,38,53,600 comprising of 11,19,26,800 Equity Shares of ? 2 each. The aforesaid intimation is also being uploaded on the website of the Company: www.advancedenzymes.com.
The above information is a part of company’s filings submitted to BSE.
